Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 5;9(1):63.
doi: 10.1186/s41747-025-00598-7.

Impact on the microstructure of deep gray matter in unvaccinated patients after moderate-to-severe COVID-19: insights from MRI T1 mapping

Affiliations

Impact on the microstructure of deep gray matter in unvaccinated patients after moderate-to-severe COVID-19: insights from MRI T1 mapping

Masia Fahim et al. Eur Radiol Exp. .

Abstract

Background: To determine changes in quantitative T1 relaxation times (qT1) in deep gray matter in patients recovered from coronavirus disease 2019 (COVID-19).

Methods: Unvaccinated COVID-19 participants ≥ 3 months after seropositivity and age- and sex-matched controls were examined using 3-T magnetic resonance imaging. Bilateral measures of thalamus, pallidum, putamen, caudate and accumbens nuclei, and hippocampus were extracted from qT1 maps after automated segmentation. Baseline characteristics and results of tests assessing neurological functions (standardized exam), ability to smell (4-Item Pocket Smell Test), depression (Beck Depression Inventory-II), sleepiness (Epworth Sleepiness Scale), sleep quality (Pittsburgh Sleep Quality Index), health-related quality of life (EQ-5D), and cognitive performance (Montreal Cognitive Assessment) were evaluated.

Results: One hundred forty-five subjects (median age, 46 years; 73 females) were included (11/2020-12/2021): 69 recovered after COVID-19 and 76 controls (age, p = 0.532; sex, p = 0.799), without significant differences in qT1 values overall (all p-values > 0.050). Subgroup analysis of participants aged ≥ 40 (age, p = 0.675; sex, p = 0.447) revealed higher qT1 values in previously hospitalized COVID-19 subjects (23/69) compared to controls (47/76) in left and right caudate nuclei (p = 0.009; p = 0.027), left accumbens nucleus (p = 0.017), right putamen (p = 0.041), and right hippocampus (p = 0.020). No correlations were found with macroscopic imaging findings, pre-existing conditions, time since COVID-19 diagnosis, inpatient treatment duration, or test results.

Conclusion: T1 mapping revealed microstructural changes in striatal and hippocampal regions of unvaccinated individuals aged ≥ 40 who recovered from moderate-to-severe COVID-19 during the pre-Omicron era.

Relevance statement: This study elucidates brain involvement following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, underscoring the need for further longitudinal analyses to assess the potential reversibility, stability or deterioration of these findings.

Key points: We hypothesized altered T1 relaxation times in deep gray matter after COVID-19. Unvaccinated participants ≥ 40 years exhibited higher striatal, hippocampal qT1 after moderate-to-severe COVID-19. No qT1 correlations were found with hospitalization duration, pre-existing conditions, or neuro-(psycho)logical tests.

Keywords: Brain mapping; COVID-19; Gray matter; Magnetic resonance imaging; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee of the Faculty of Medicine at Goethe University Frankfurt, Germany (20-838) and registered at the German Clinical Trials Register (DRKS00023880). The study was conducted in accordance with the ethical guidelines for research involving human subjects, according to the Declaration of Helsinki. Guarantor: The scientific guarantor of this publication is Prof Dr Elke Hattingen. Consent for publication: Each participant signed an informed consent form for research. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Box plots of qT1 values in five regions of interest, showing compelling trends of increased values in previously hospitalized COVID-19 patients versus controls, all of whom were unvaccinated and aged 40 years or older. Data were analyzed using Wilcoxon–Mann–Whitney U tests, stratified by age and controlled for false discoveries by the Benjamini-Hochberg method. Five deep gray matter regions (x-axis) showed significant differences (Δ) in qT1 values (y-axis; [ms]) between the subgroup of controls (n = 47; box plots further to the left) and recovered COVID-19 patients (n = 23; box plots further to the right). COVID-19, Coronavirus disease 2019; qT1, Quantitative T1 relaxation times
Fig. 2
Fig. 2
Representative case of a recovered COVID-19 patient with MRI-detectable macro- and microstructural brain changes. The 66-year-old male subject was hospitalized for over 3 months due to COVID-19. The MRI protocol included a conventional FLAIR sequence (a) and a synthetic anatomical MP-RAGE sequence (b), the latter of which was also used for software-based automatic segmentation of multiple deep gray matter structures. The visually interpreted images (a, b) revealed a lacuna in the left dorsal putamen (white arrowheads), which was excluded from the qT1 measurements (threshold exceeded). MRI qT1 maps showed increased qT1 values predominantly in the left caudate and accumbens nuclei (subject’s median qT1: 1,563 ms and 1,818 ms versus median qT1 of the never-infected controls aged ≥ 40: 1,398 ms and 1,644 ms), without any apparent lesions on conventional images. COVID-19, Coronavirus disease 2019; FLAIR, Fluid-attenuated inversion recovery; MP-RAGE, Magnetization-prepared rapid acquisition gradient-echo; MRI, Magnetic resonance imaging; qT1, Quantitative T1 relaxation times

References

    1. Harapan BN, Yoo HJ (2021) Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 268:3059–3071. 10.1007/s00415-021-10406-y - PMC - PubMed
    1. Pensato U, Muccioli L, Cani I et al (2021) Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy. Ann Clin Transl Neurol 8:968–979. 10.1002/acn3.51348 - PMC - PubMed
    1. Mahalaxmi I, Kaavya J, Mohana DS et al (2021) COVID‐19 and olfactory dysfunction: a possible associative approach towards neurodegenerative diseases. J Cell Physiol 236:763–770. 10.1002/jcp.29937 - PMC - PubMed
    1. Thakur KT, Miller EH, Glendinning MD et al (2021) COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 144:2696–2708. 10.1093/brain/awab148 - PMC - PubMed
    1. Song E, Zhang C, Israelow B et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 10.1084/jem.20202135 - PMC - PubMed

LinkOut - more resources